期刊文献+

冠状动脉CT血管造影评价阿托伐他汀对轻中度冠状动脉狭窄斑块逆转作用研究 被引量:4

Observation of the reverse effect of atorvastatin on angina plaque in patients with mild-to-moderate coronary artery stenosis by coronary artery computed tomography
原文传递
导出
摘要 目的评价阿托伐他汀对轻中度冠状动脉狭窄的稳定型心绞痛患者的斑块逆转作用。方法对2011年11月至2012年6月沈阳军区总医院收治的42例冠状动脉CT显示冠状动脉轻中度狭窄的稳定型心绞痛患者随机分为2组:阿托伐他汀20mg组22例,阿托伐他汀40mg组20例。所有患者于入院前已完成冠脉cT血管造影(CTA),并接受冠状动脉造影(CAG)和靶病变的血管内超声(IVUS)检查,冠状动脉CT与冠状动脉造影及血管内超声相符合者入选。每位患者选取1处狭窄30%-60%的病变为靶病变进入观察,于术后6—12个月后行冠状动脉CTA评价,比较治疗前后冠状动脉靶病变的斑块面积。结果阿托伐他汀20mg组低密度脂蛋白胆固醇(LDL—c)由(3.44±0.42)mmol/L降至(2.31±0.19)mmo]/L,总胆固醇(TC)由(5.89±1.48)mmoVL降至(3.37±0.21)mmol/L;阿托伐他汀40mg组LDL—C由(3.52±0.43)mmol/L降至(1.83±0.17)mmol/L,TC由(5.99±1.28)mmol/L降至(3.17±0.10)mmol/L。斑块面积在入院时两组差异无统计学意义。降脂治疗后阿托伐他汀20mg组斑块面积由(13.16±4.79)mm。减少至(12.28±2.36)mm。(P=0.37);阿托伐他汀40nlg组斑块面积由(13.81±4.52)mm。减少至(9.93±2.28)mm。(P〈0.01)。结论40mg/d阿托伐他汀可以使冠状动脉轻中度狭窄的稳定型心绞痛患者的斑块面积减少,可以阻止冠状动脉斑块的进展,效果好于20mg/d阿托伐他汀。 Objective To evaluate reversal effect of atorvastatin on angina plaque in patients with mild-to-moderate coronary artery stenosis. Methods Forty-two stable angina cases with mild-to-moderate coronary artery stenosis observed by coronary artery computed tomography (CT) were randomly divided into two groups ,treated with 20 mg and 40 mg atorvastatin, respectively. All patients had received CT angiography ( CTA), coronary artery angiography (CAG) and intravaseular ultrasound (IVUS) examination before admission. Patients whose CTA results were consistent with CAG/IVUS were enrolled. We selected a 30% - 60% lesion in every patient that served as the target lesion. The coronary artery plaque area was compared before and after treatment (6 - 12 months) by CTA. Results The level of low-density lipoprotein cholesterol ( LDL- C) in patients treated with 20 mg atorvastatin reduced from (3.44 ±0. 42)mmol/L to (2. 31± 0. 19)mmol/L,and also did the level of total cholesterol (TC) from (5.89 ±1.48 ) mmol/L to ( 3.37 ±0. 21 ) mmol/L. The level of LDL-C in patients treated with 40 mg atorvastatin reduced from ( 3.52±0. 43 ) mmol/L to ( 1.83 ±0. 17 ) retooL/L, and also did TC from (5.99 ± 1.28)mmol/L to (3.17 ± 0. 10)mmol/L. The plaque area at admission was not significantly different between the two groups. The plague area of patients treated with 20 mg atorvastatin was decreased from ( 13. 16 ±4. 79) mm2 to (12. 28 ± 2. 36)mm2 (P =0. 37), and the plague area of patients treated with 40 mg atorvastatin was decreased from (13.81 ±4. 52 ) mm2 to ( 9. 93 ± 2.28)mm2(P〈0.01).Conclusion Atorvastatin at a dose of 40 mg/d can reduce the angina plague area in patients with mild-to-moderate coronary artery stenosis, and the effect is superior to that of 20 mg/d atorvastatin.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第4期379-382,共4页 Chinese Journal of Practical Internal Medicine
基金 辽宁省自然科学基金(201101137)
关键词 阿托伐他汀 冠状动脉CTA 稳定型心绞痛 斑块面积 斑块逆转 atorvastatin coronary artery computed tomography stable angina plaque area plaque reversal
  • 相关文献

参考文献12

  • 1Nissen SE, Tuzcu EM, Schoenhagen P , et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial [J] . JAMA ,2004, 291(9) :1071-1080.
  • 2Ballantyne CM, Raichlen JS, Nicholls SJ, et al. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden [J]. Circulation ,2008,117 (19) :2458 - 2466.
  • 3王志国,盖鲁粤,蒋博,任学文,汪奇,杨霞,李萍,陈韵岱,杨立,关志伟.多排CT评价冠状动脉斑块变化与血脂的关系[J].军医进修学院学报,2010,31(5):449-451. 被引量:5
  • 4Grundy SM, Cleeman JI, Merz CN , et al. Implications of recent clinical trials for the National Cholesterol Education Program Aduh Treatment Panel II guidelines [J ]. Circulation, 2004, 110 ( 2 ) : 227 -239.
  • 5中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5227
  • 6Leeper NJ , Ardehali R, deGoma EM , et al. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival[J]. Circulation,2007 ,116(6) :613 -618.
  • 7Okazaki S, Yokoyama T , Miyauchi K, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial efect on atheIDsclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study [J]. Circulation,2004 ,110(9) : 1061 -1068.
  • 8Sanguineti MC ,Curran ME,Zou A,et al. Coassembly of K( V) LQT1 and minK (lsK) proteins to form cardiac I (Ks) potassium channel [J]. Nature,1996,384(6604) .so -83.
  • 9Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of intensive LDL-cholesterol-lowering therapy: a meta-analysis of data from 170 000 participants in 26 randomized trials [J]. Lancet,2010,376:1670 -1681.
  • 10彭定凤,唐哨勇,胡勇钧.普伐他汀对血脂正常高血压患者血压及高敏C反应蛋白水平的影响[J].吉林大学学报(医学版),2012,38(5):1042-1042. 被引量:6

二级参考文献176

共引文献5280

同被引文献41

  • 1王青山.阿托伐他汀联合曲美他嗪治疗冠心病的疗效[J].中国老年学杂志,2014,34(10):2743-2744. 被引量:78
  • 2俞章平,余晗俏,钟忆周,梁亚非,高文涛.依折麦布联合阿托伐他汀对急性冠状动脉综合征患者血脂指标及血管内皮功能的影响[J].中国生化药物杂志,2014,34(6):110-112. 被引量:24
  • 3MOHR F W, MORICE M C, KAPPETEIN A P, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three -vessel disease and left main coronary disease: 5 - year follow - up of the randomised, clinical SYNTAX trial[ J]. Lancet, 2013, 381 (9867) : 629 -638.
  • 4DRENGER B, FONTES M L, MIAO Yinghui, et al. Patterns of use of perioperative angiotensin - converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in - hospital morbidity and mortality [ J ]. Circulation, 2012, 126 (3) : 261 - 269.
  • 5Adel A, Mohamed AH, Nammas W, etal. Would coronary collaterals to the infarct-related artery serve as a marker of viability in patients with prior myocardial infarction? A study with trimetazidine- (99m)Tc- sestamibi imaging[J]. Cardio- vasc Revasc Med, 2011, 12(1):41-46.
  • 6Xu X, Zhang W, Zhou Y, et al. Effect of trimetazidine on re- curreri/' angina pectoris and left ventricular structure in el- derly muhivessel coronary heart disease patients with diabe- tes mellitus after drug-eluting stent implantation: a single- centre, prospective, randomized, double-blind study at 2- year follow-up[J]. Clin Drug lnvestig, 2014, 34(4):251-258.
  • 7Dehina L, Vaillant F, Tabib A, et al. Trimetazidine demon- strated cardioprotective effects through mitochondrial path- way in a model of acute coronary ischemia[J]. Naunyn Schmiedebergs Arch Pharmacol, 2013, 386(3):205-215.
  • 8Zhang N, Lei J, Liu Q, et al. The effectiveness of preopera- tive trimetazidine on myocardial preservation in coronary ar- tery bypass graft patients: a systematic review and meta- analysis[J]. Cardiology, 2015, 131(2):86-96.
  • 9毛芸,阚晓婧,吕发金,罗天友.心肌桥:冠状动脉CT血管成像与传统冠状动脉造影对比研究[J].重庆医科大学学报,2010,35(2):241-244. 被引量:8
  • 10黄小宁,李晓,邓军,左敏静,刘贯清,彭碧波.64层CT评价冠脉粥样斑块性质与狭窄程度的相关性[J].放射学实践,2011,26(4):414-418. 被引量:14

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部